Clinical trials
Immunity clinical trials
Below are recruiting immunity clinical trials, each written for real people, not researchers. We’re tracking 973 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07024238Enrolling by invitation
Short-chain fatty acid supplement for kidney transplant patients
This study tests whether taking a short-chain fatty acid (a type of fiber-like substance) supplement can improve gut health in people who have had a kidney transplant. It may help keep the transplant working well.
Martin, SlovakiaAges 18 years+ - NCT06993727Recruiting
Autoimmune antibodies before immunotherapy
This study is looking for people about to start immune checkpoint inhibitor therapy to see if certain antibodies are present. It may help understand how the body reacts to this treatment.
BrusselsAges 18 years+ - NCT07021209RecruitingPhase 1
GT719 for returning or hard-to-treat autoimmune neurological diseases
This trial tests a new antibody drug (GT719) for adults with autoimmune neurological diseases that came back or did not get better with standard treatment. It looks at how safe the drug is and how well it works.
Wuhan, HubeiAges 18–75 - NCT07020156RecruitingPhase 1
First test of drug OX118 in healthy people
This early-phase trial tests a new drug called OX118 in healthy volunteers to see if it is safe and how the body processes it. It is a first step in developing a potential new treatment.
UppsalaAges 18–60 - NCT07018076Recruiting
TB treatment study for people who just finished therapy
This study looks for people who have recently completed standard treatment for drug-sensitive TB. Researchers want to check if certain tests can predict long-term health outcomes after treatment.
KampalaAges 12 years+ - NCT07020533RecruitingPhase 1
CMV vaccine for stem cell transplant recipients
This trial tests a vaccine designed to boost immunity against CMV (a common virus) and prevent active CMV infection in people receiving a half-matched stem cell transplant. It may help protect you from CMV-related complications after transplant.
Duarte, CaliforniaAges 18–75 - NCT07019857Recruiting
Thymus removal and immunity in infant heart surgery
This study looks at how removing the thymus gland during infant heart surgery affects the immune system. It compares babies who have their thymus removed with those who have heart surgery without removing it, and with babies having other types of surgery.
NantesAges Up to 6 months - NCT05324475Recruiting
Nutritional supplement to support immunity and energy in older adults
This trial tests whether a safe nutrition supplement can help older adults with malnutrition maintain immune function and energy (mitochondrial function). It may support recovery during rehabilitation, but you must meet specific nutrition and health criteria.
Lausanne, SwitzerlandAges 75 years+ - NCT06797024Recruiting
Study of JY231 injection for tough nerve immune disorders
This trial tests a new injection called JY231 for people with certain hard-to-treat nerve and immune disorders that haven't improved with standard treatments. It aims to see if this experimental therapy can help control the disease when other options have failed.
Wuhan, HubeiAges 18–75 - NCT07011238Recruiting
Memory B cells and anti-HLA antibodies in kidney transplant patients
This study looks at how memory B cells (a type of immune cell) relate to antibodies against HLA in people waiting for a kidney transplant. It aims to better understand immune responses, which could help improve transplant matching and outcomes.
RouenAges 18 years+ - NCT07003334Recruiting
Study on mental health and immune therapy for stomach cancer
This study looks at how psychological distress relates to immune checkpoint inhibitors in people with stomach cancer. It may help understand if emotional well-being affects treatment response.
Guangzhou, GuangdongAges 18–75 - NCT07004868Recruiting
Inflammation & treatment response in lung cancer immunotherapy
This study looks at how inflammation and body changes (like weight loss) affect how well immunotherapy works in lung cancer. If you are starting immunotherapy at the hospital in Tours, your doctors will collect information from your regular care to learn more about your response.
ToursAges 18 years+ - NCT07010822RecruitingPhase 3
New Polio Vaccine for Newborns: Gut Protection Study
This study tests giving a new polio vaccine (nOPV2) right after birth to see how well it protects the gut. It is for healthy, full-term newborns whose parents agree to participate.
Chāndpur, Dhaka DivisionAges 1 day–1 week - NCT06999954Recruiting
Global survey for Shwachman-Diamond syndrome and related conditions
This trial is a global survey and registry for people with Shwachman-Diamond Syndrome and related inherited blood disorders. It aims to connect patients, families, and researchers to better understand these conditions and improve care.
Woburn, MassachusettsAges Any age - NCT06998264Recruiting
Immune response to flu in young children
This study looks at how children's immune systems fight the flu in the nose and throat. It aims to understand why some children get very sick and others don't, which could help create better treatments and vaccines.
GenevaAges 2–5 - NCT06998251Recruiting
Immune response to strep pneumonia in older adults
This study looks at how the immune system in the nose and throat reacts to Streptococcus pneumoniae bacteria and viruses in adults aged 60-85. It may help researchers find better ways to prevent or treat pneumonia.
GenevaAges 60–85 - NCT07003009Recruiting
Immunotherapy washout study for invasive ductal breast cancer
This study looks at how long it takes for a type of immunotherapy drug to clear out of your body in women with invasive ductal breast cancer who are about to start treatment before surgery. It may help doctors decide the best timing for future treatments.
IstanbulAges 18 years+ - NCT07000708Recruiting
Vaccination, time-restricted eating, aging, and lifestyle study
This trial tests whether time-restricted eating (eating only during an 8-hour window each day) can improve how well your body responds to flu and COVID-19 vaccines. It is designed for older adults who want to see if this simple eating pattern boosts their immune system.
BerlinAges 60–85 - NCT06996652RecruitingPhase 2
Study of adalimumab to delay Parkinson's symptoms in sleep disorder
This trial tests whether adalimumab, an immune system drug, helps people with REM sleep behavior disorder (a condition that may warn of Parkinson's disease) stay healthy longer. Participants will receive injections of the drug or a placebo to see if it prevents Parkinson's-related brain problems.
Los Angeles, CaliforniaAges 50–80 - NCT06983899Recruiting
Exercise to boost immunity during lung cancer immunotherapy
This trial tests whether a supervised exercise program can help improve immune activity and treatment outcomes for people with non-small cell lung cancer who are already on immunotherapy. It is designed for people who are not currently very active.
Seattle, WashingtonAges 18 years+ - NCT06980480RecruitingPhase 3
Gammagard to prevent infections in multiple myeloma
This study tests if adding Gammagard (a type of antibody therapy) to your multiple myeloma treatment with Tecvayli can help prevent serious infections. You may qualify if you recently started Tecvayli and are still responding to it.
Mobile, AlabamaAges 18 years+ - NCT06858683Recruiting
Time-restricted eating study for people with obesity
This study tests if eating only within a certain time window each day can improve immune function in people with obesity who are planning bariatric surgery. You would follow a time-restricted eating plan for 10-12 weeks before your surgery to see how it affects your health.
BarcelonaAges 18–64 - NCT06063681RecruitingPhase 1
Testing a new ENPPI inhibitor for advanced solid tumors
This trial tests a new drug, SR-8541A, that blocks an enzyme called ENPPI, which may help slow or stop tumor growth. It is for people with advanced or metastatic solid tumors who have not responded to other treatments or have no standard options.
Randwick, New South WalesAges 18 years+ - NCT06966687Enrolling by invitation
Ulinastatin and thymosin for immune support after aortic dissection surgery
This trial tests whether two anti-inflammatory drugs, ulinastatin and thymosin α1, can help protect your immune system and organs after emergency surgery for a torn aorta (aortic dissection). If you qualify and take part, you may receive these medications in addition to standard care.
Beijing, Beijing MunicipalityAges 18–80
Hear when a new Immunity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for immunity?
- Yes. Clin2 currently lists 973 recruiting immunity studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a immunity trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a immunity trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.